Daphnetin exerts an anticancer effect by attenuating the pro-inflammatory cytokines

Area of Science:

• Biomedical Science
• Pharmacology
• Oncology

Background:

• Leukemia is a malignant disease characterized by immature blood cell overproduction.
• Inflammation is a key factor in leukemia progression.
• Daphnetin is known for its anti-inflammatory properties.

Purpose of the Study:

• To investigate the anti-leukemia and anti-inflammatory effects of daphnetin.
• To explore the underlying mechanisms of daphnetin's action in benzene-induced leukemia.
• To evaluate daphnetin's impact on hematological parameters and inflammatory mediators.

Main Methods:

• Benzene was used to induce leukemia in experimental rats.
• Rats were divided into treatment and control groups.
• Body weight, hematological parameters, bone marrow cells, cytokines, inflammatory mediators, and mRNA expression of sphingosine-1-phosphate receptor-1 were analyzed using RT-PCR.

Main Results:

• Daphnetin treatment led to increased body weight and reduced leukemic blasts.
• Hematological parameters, including red and white blood cells, were favorably altered.
• Daphnetin significantly reduced pro-inflammatory cytokines (TNF-α, IL-1β, IL-2, IL-6) and nuclear factor-κB.
• Sphingosine-1-phosphate receptor-1 mRNA expression was upregulated in daphnetin-treated rats.

Conclusions:

• Daphnetin exhibits significant anti-leukemia and anti-inflammatory effects in a rat model of benzene-induced leukemia.
• The anti-inflammatory action of daphnetin is associated with the modulation of cytokines and inflammatory mediators.
• Daphnetin represents a potential therapeutic agent for leukemia, warranting further investigation.